Carregant...
Comparative research on (99m)Tc-Rituximab and (99m)Tc-sulfur colloid in sentinel lymph node imaging of breast cancer
BACKGROUND: (99m)Tc-Rituximab is a new specific radiopharmaceutical that binds to the CD20 receptor which is highly expressed on the surface of B cells. We conducted a study in which (99m)Tc-Rituximab was compared with filtered (99m)Tc-sulfur colloid (fTcSC) for sentinel lymph node (SLN) detection i...
Guardat en:
| Publicat a: | BMC Cancer |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6794795/ https://ncbi.nlm.nih.gov/pubmed/31615471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6197-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|